Evidence map›Paper›PMID 38182037›Full record

ArticleBrain, behavior, and immunity2024

Intermittent cytomegalovirus infection alters neurobiological metabolism and induces cognitive deficits in mice.

Mark A A Harrison, Sara L Morris, Grace A Rudman, Daniel J Rittenhouse, Chandler H Monk, Siva S V P Sakamuri, Md Mehedi Hasan, Mst Shamima Khatun, Hanyun Wang, Lucas P Garfinkel and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Mark A A HarrisonNeuroscience Program, Tulane Brain Institute, Tulane University School of Science & Engineering, New Orleans, LA 70112, USA; Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Sara L MorrisBiomedical Sciences Program, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Grace A RudmanDepartment of Environmental Studies, Tulane University School of Liberal Arts, New Orleans, LA 70112, USA.
Daniel J RittenhouseDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Center for Translational Research in Infection & Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Chandler H MonkBioinnovation Program, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Siva S V P SakamuriDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Md Mehedi HasanTulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Mst Shamima KhatunTulane Center for Translational Research in Infection & Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Hanyun WangDepartment of Neurosurgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Lucas P GarfinkelDepartment of Neurosurgery, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Elizabeth B NortonDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Sangku KimTulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jay K KollsDeming Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Center for Translational Research in Infection & Inflammation, Tulane University School of Medicine, New Orleans, LA 70112, USA.
S. Michal JazwinskiTulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA; Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Ricardo MostanyDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Prasad V G KatakamDepartment of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Elizabeth B Engler-ChiurazziTulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Neurosurgery, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: eenglerchiurazzi@tulane.edu.
Kevin J ZwezdarykDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: kzwezdar@tulane.edu.
Tulane University · US

Funding

The role of the CMV-associated reactive oxygen species in age-relatedP20GM103629 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI SAMMARCO, MIMI C · 2012 to 2021
$22.4M
Pilot Projects ProgramP30GM145498 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI S MICHAL JAZWINSKI · 2022 to 2026
$8.6M
Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
Peroxynitrite is a Molecular Determinant of Impaired Microvascular Energetics in Alzheimer's DiseaseR01AG074489 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI KATAKAM, PRASAD V, MOSTANY, RICARDO · 2021 to 2025
$3.2M
Cerebral Microvascular Bioenergetics and Neurovascular CouplingR01NS114286 · NINDS · TULANE UNIVERSITY OF LOUISIANA · PI KATAKAM, PRASAD V, MOSTANY, RICARDO · 2020 to 2024
$2.5M
The Role of Viral Exposure and Age in Alzheimer's Disease ProgressionR01AG082899 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI Kevin John Zwezdaryk · 2023 to 2026
$2.1M
Interdisciplinary Predoctoral Training in BioinnovationT32EB027632 · NIBIB · TULANE UNIVERSITY OF LOUISIANA · PI GAVER, DONALD P. · 2019 to 2023
$813k
Assessment of Mechanisms Underlying B Cell Impacts on Resilience and Susceptibility to StressK01MH117343 · NIMH · WEST VIRGINIA UNIVERSITY · PI ENGLER-CHIURAZZI, ELIZABETH · 2020 to 2023
$576k
Dysfunctional homeostatic plasticity in Alzheimer's DiseaseR56AG072676 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI MOSTANY, RICARDO · 2021 to 2021
$425k
NHLBI NIH HHS R35 HL139930NIA NIH HHS R01 AG074489NIA NIH HHS R01 AG082899NIA NIH HHS R56 AG072676NIBIB NIH HHS T32 EB027632NIGMS NIH HHS P20 GM103629NIGMS NIH HHS P30 GM145498NIMH NIH HHS K01 MH117343NINDS NIH HHS R01 NS114286
6 · The paper itself

Abstract

Risk factors contributing to dementia are multifactorial. Accumulating evidence suggests a role for pathogens as risk factors, but data is largely correlative with few causal relationships. Here, we demonstrate that intermittent murine cytomegalovirus (MCMV) infection of mice, alters blood brain barrier (BBB) permeability and metabolic pathways. Increased basal mitochondrial function is observed in brain microvessels cells (BMV) exposed to intermittent MCMV infection and is accompanied by elevated levels of superoxide. Further, mice score lower in cognitive assays compared to age-matched controls who were never administered MCMV. Our data show that repeated systemic infection with MCMV, increases markers of neuroinflammation, alters mitochondrial function, increases markers of oxidative stress and impacts cognition. Together, this suggests that viral burden may be a risk factor for dementia. These observations provide possible mechanistic insights through which pathogens may contribute to the progression or exacerbation of dementia.

Indexed as

Cognition DisordersCognitive DysfunctionCytomegalovirus InfectionsDementiaAnimalsCognitionMiceAgingAlzheimer’s diseaseBlood brain barrierBrain microvascular endothelial cellsCognitive declineCytomegalovirusDementiaMetabolismOxidative stressPathogen

Identifiers

PMID38182037
PMCPMC11914963
OpenAlexW4390570759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.